News: U.S. and World News Headlines : NPR
3 days ago · NPR news, audio, and podcasts. Coverage of breaking stories, national and world news, politics, business, science, technology, and extended coverage of major national and …
U.S. News and National Top Stories : NPR
3 days ago · NPR coverage of national news, U.S. politics, elections, business, arts, culture, health and science, and technology. Subscribe to the NPR Nation RSS feed.
The anatomy of an NPR headline : NPR Public Editor : NPR
Apr 17, 2025 · The goal of a good headline is multipronged, according to Thomas Evans, managing editor, editorial review, who joined NPR last fall to lead the creation of what's called …
Latin superstar Bad Bunny will headline the 2026 Super Bowl ... - NPR
Sep 29, 2025 · Puerto Rican rapper and singer Bad Bunny will headline next year's Super Bowl halftime show.
World News and International Headlines : NPR
2 days ago · NPR world news, international art and culture, world business and financial markets, world economy, and global trends in health, science and technology. Subscribe to the World …
How to write great headlines that keep readers engaged
Oct 25, 2015 · So when you're writing your headline, make sure people can easily understand it. Keep it simple — avoid names and acronyms that aren't universally recognized.
Trump defends use of U.S. military against 'enemy within' : NPR
Sep 30, 2025 · President Trump defended the use of U.S. troops in American cities and told top U.S. commanders that the military would be used against the "enemy within." "This is going to …
Why Shedeur Sanders is the biggest headline out of the NFL draft
Apr 28, 2025 · Sports Why Shedeur Sanders is the biggest headline out of the NFL draft April 28, 20254:55 PM ET Heard on All Things Considered By
Morning Edition for January 7, 2026 : NPR
Jan 7, 2026 · Hear the Morning Edition program for Jan 07, 2026
Trump aims to lower drug prices with new executive order : Shots ...
May 12, 2025 · President Trump wants to lower drug prices in the U.S. by tying them to the prices paid in other developed countries. The pharmaceutical industry has long opposed the approach.